Increase in allergy following donor lymphocyte infusions [3]

Bone Marrow Transplantation

Volumn 37, Issue 10, 2006, Pages 983-984

  Yong, P F K ^a   Grosse Kreul, D ^a   Devereux, S ^a   Pagliuca, A ^a   Maher, J ^a   Ibrahim, M A A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLERGY; BONE MARROW TRANSPLANTATION; CANCER RELAPSE; CASE REPORT; DIARRHEA; DONOR; DONOR LYMPHOCYTE INFUSION; ECZEMA; FEMALE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LETTER; OUTCOME ASSESSMENT; PRICK TEST; PRIORITY JOURNAL; RHINITIS; SIBLING; URTICARIA;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; HYPERSENSITIVITY; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; TIME FACTORS;

EID: 33646950673     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705363     Document Type: Letter

References (9)

1. Agosti JM, Sprenger JD, Lum LG, Witherspoon RP, Fisher LD, Storb R et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988; 319: 1623-1628.
2. Shalit M, Amar A, Or R. Allergy development after bone marrow transplantation from a non-atopic donor. Clin Exp Allergy 2002; 32: 1699-1701.
3. Dreskin SL, Goldsmith PK, Strober W, Zech LA, Gallin JI. Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. J Clin Invest 1987; 79: 1764-1772.
4. Loveless MH. Immunological studies of pollinosis II. Passive sensitisation of man through transfusion. J Immunol 1941; 41: 15-34.
5. Nash RA, Storb R. Graft-versus-host effect after allogeneic stem cell transplantation: GVHD and GVL. Curr Opin Immunol 1996; 8: 674-680.
6. Strom TB, Roy-Chaudhury P, Manfro R, Zheng XX, Nickerson PW, Wood K et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688-693.
7. Morris EC, Rebello P, Thomson KJ, Peggs KS, Kyriakou C, Goldstone AH et al. Pharmacokinetics of Alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: Relevance for early adoptive immunotherapy and infectious complications. Blood 2003; 102: 404-406.
8. Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N et al. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells. Bone Marrow Transplant 2000; 26: 69-76.
9. Gennery AR, Cant AJ. Development of allergy post-bone marrow transplantation. Clin Exp Allergy 2002; 32: 1677-1678.